Company news
Kyorin Pharmaceutical Co.,ltd. (TSE:4569) news
Kyorin Pharmaceutical Co.,ltd. news releases on 6ix. Latest, Sep 30, 2026: (Update on Disclosed Matter) Notice Regarding Transfer of Generic Drug Business
Press releases & updates
(Update on Disclosed Matter) Notice Regarding Transfer of Generic Drug Business
September 30, 2026
KYORIN to Commence Promotion Activities for Allergic Conjunctivitis Treatment Alesion Eyelid Cream 0.5%
August 3, 2026
[Summary]Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]
July 30, 2026
KYORIN Entered into Joint Marketing Agreement in Japan for Allergic Conjunctivitis Treatment Alesion Eyelid Cream 0.5%
July 13, 2026
KYORIN Pharmaceutical: Operating profit fell 71.6% year-over-year as sales declined and R&D costs rose
May 12, 2026
Kyorin Pharmaceutical Co Ltd - Kyorin Enters Into License Agreement With Biodol For Novel Neuropathic Pain Treatment
March 31, 2026
TABLE-Kyorin Pharmaceutical - 9-MTH group results
February 4, 2026
KYORIN Pharmaceutical: Strong nine-month results, but full-year outlook projects lower sales and profits
February 3, 2026
KYORIN Pharmaceutical: Net sales rose 6.5% YoY, but operating profit fell on higher R&D; guidance unchanged
November 7, 2025
Kyorin Pharmaceutical Co Ltd - Kyorin And Hinge Bio Enter Into A Collaboration And License Agreement Of Hb2198 In Japan For Sle And Other Diseases
September 30, 2025
KYORIN Pharmaceutical: Strong Q1 profit growth, but full-year outlook projects lower sales and earnings
July 30, 2025
KYORIN Pharmaceutical: Strong profit growth this year, but next year's outlook signals a significant earnings decline
May 12, 2025
KYORIN Pharmaceutical: Sales and operating profit rose, but net profit and comprehensive income fell sharply year-over-year
February 5, 2025
KYORIN Pharmaceutical: Sales and profits rose, but net income fell; full-year outlook expects modest growth
November 6, 2024
KYORIN Pharmaceutical: Q1 FY2024 delivered higher sales and profits, but FY2025 profit is forecast to decline
July 31, 2024